Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Enveric Biosciences Inc (ENVB)

Enveric Biosciences Inc (ENVB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2300 +0.0400 (+3.36%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.1900 -0.0400 (-3.25%) 17:32 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1500
Day High
1.2700
Open 1.2700
Previous Close 1.1900 1.1900
Volume 41,500 41,500
Avg Vol 65,270 65,270
Stochastic %K 46.94% 46.94%
Weighted Alpha -89.80 -89.80
5-Day Change -0.0400 (-3.15%) -0.0400 (-3.15%)
52-Week Range 1.0100 - 15.4500 1.0100 - 15.4500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,941
  • Shares Outstanding, K 2,472
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,570 K
  • EBIT $ -9 M
  • EBITDA $ -9 M
  • 60-Month Beta 0.65
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -9.15
  • Growth Rate Est. (year over year) +11,018.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0100 +21.78%
on 04/09/25
Period Open: 1.7400
1.7700 -30.51%
on 03/24/25
-0.5100 (-29.31%)
since 03/21/25
3-Month
1.0100 +21.78%
on 04/09/25
Period Open: 4.9650
5.0985 -75.88%
on 01/24/25
-3.7350 (-75.23%)
since 01/22/25
52-Week
1.0100 +21.78%
on 04/09/25
Period Open: 12.9150
15.4500 -92.04%
on 05/08/24
-11.6850 (-90.48%)
since 04/22/24

Most Recent Stories

More News
8 Small-Cap Stocks Surging Like Rockets After Game-Changing News

Small-cap stocks often deliver some of the most explosive gains when game-changing news hits the market. Investors searching for high-upside opportunities should pay attention to this week’s biggest...

RILY : 3.03 (+2.71%)
MLGO : 9.83 (-17.12%)
ENVB : 1.2300 (+3.36%)
RETO : 3.64 (+18.95%)
PEPG : 1.6200 (+6.58%)
STEC : 0.9550 (-9.91%)
ONVO : 2.0100 (+14.86%)
GDEV : 11.50 (+5.19%)
Enveric Biosciences (NASDAQ: ENVB) Obtains Notice of Allowance For a U.S. Patent Covering Its Innovative Psilocin Prodrug, EB-373

Enveric Biosciences, Inc. (NASDAQ: ENVB) is engaged as a biotechnology company, which focused on the research and development of innovative

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Celebrates and Supports 2023 Mental Health Awareness Month

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences to Participate in Benzinga Psychedelics Capital Conference

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)
Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression,...

ENVB : 1.2300 (+3.36%)

Business Summary

Enveric Biosciences Inc. is a patient-centric biotechnology company endeavoring to enhance the lives of Cancer Treatments with novel cannabinoid medicines. Enveric Biosciences Inc., formerly known as AMERI Holdings Inc., is based in NAPLES, Fla.

See More

Key Turning Points

3rd Resistance Point 1.4033
2nd Resistance Point 1.3367
1st Resistance Point 1.2833
Last Price 1.2300
1st Support Level 1.1633
2nd Support Level 1.0967
3rd Support Level 1.0433

See More

52-Week High 15.4500
Fibonacci 61.8% 9.9339
Fibonacci 50% 8.2300
Fibonacci 38.2% 6.5261
Last Price 1.2300
52-Week Low 1.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro